LYNWOOD CAPITAL MANAGEMENT INC. BriaCell Therapeutics Corp. Transaction History

LYNWOOD CAPITAL MANAGEMENT INC. portfolio value:

$6.73M
portfolio value

LYNWOOD CAPITAL MANAGEMENT INC. quarter portfolio value change:

-2.60%
quarter

BriaCell Therapeutics Corp. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase +94.80% 583K shares 3.18M $5.62 1.19M
Q2 2022 share Decrease -18.00% -135K shares -4.05M $5.77 615K
Q1 2022 share Decrease -4.46% -35K shares 1.10M $10.14 750K
Q4 2021 share Increase 0.00% 785K shares 6.5M $8.35 785K